Jean-Marie Eveillard - First Eagle Investment Management,
Period:    Q1 2026
Portfolio date:    31 Mar 2026
No. of stocks:    418
Portfolio value:    $58,918,305,053
Holdings Activity Buys Sells    History
Holding/activity history for  Teva Pharmaceutical Industries Ltd. (TEVA)
Period Shares % of Portfolio Activity % Change to Portfolio Reported Price Value Filing
2018   Q1 0 0.00 Sell 100.00% SEC
2017   Q4 200 0.00 $20.00 $4,000 SEC
2017   Q3 200 0.00 $20.00 $4,000 SEC
2017   Q2 200 0.00 $35.00 $7,000 SEC
2017   Q1 200 0.00 $30.00 $6,000 SEC
2016   Q4 200 0.00 $35.00 $7,000 SEC
2016   Q3 200 0.00 $45.00 $9,000 SEC
2016   Q2 200 0.00 Reduce 99.99% 0.26 $50.00 $10,000 SEC
2016   Q1 1,915,660 0.26 Reduce 56.18% 0.41 $53.51 $102,507,000 SEC
2015   Q4 4,371,619 0.73 Reduce 2.14% 0.01 $65.64 $286,953,000 SEC
2015   Q3 4,467,011 0.66 Add 18.90% 0.10 $56.46 $252,207,000 SEC
2015   Q2 3,756,998 0.54 Reduce 10.66% 0.07 $59.10 $222,039,000 SEC
2015   Q1 4,205,481 0.64 Add 71.77% 0.27 $62.30 $262,002,000 SEC
2014   Q4 2,448,310 0.35 Add 72.35% 0.15 $57.51 $140,803,000 SEC
2014   Q3 1,420,580 0.20 Add 710,190.00% 0.20 $53.75 $76,356,000 SEC
2014   Q2 200 0.00 $50.00 $10,000 SEC
2014   Q1 200 0.00 $55.00 $11,000 SEC
2013   Q4 200 0.00 $40.00 $8,000 SEC
2013   Q3 200 0.00 $40.00 $8,000 SEC
2013   Q2 200 0.00 $40.00 $8,000 SEC
2013   Q1 200 0.00 $40.00 $8,000 SEC
2012   Q4 200 0.00 $35.00 $7,000 SEC
2012   Q3 200 0.00 $40.00 $8,000 SEC
2012   Q2 200 0.00 $40.00 $8,000 SEC
2012   Q1 200 0.00 $45.00 $9,000 SEC
2011   Q4 200 0.00 $40.00 $8,000 SEC
2011   Q3 200 0.00 $35.00 $7,000 SEC
2011   Q2 200 <0.01 $50.00 $10,000 SEC
2011   Q1 200 <0.01 Buy <0.01 $50.00 $10,000 SEC
2010   Q4 0 0.00 Sell 100.00% <0.01 SEC
2010   Q3 200 <0.01 $55.00 $11,000 SEC
2010   Q2 200 <0.01 Buy <0.01 $50.00 $10,000 SEC